JANNA LISTER: Open Payments
NPI 1528478344 · ADAIRSVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$488 in 28 payments from 12 companies in 2025. Trend: 2023 $272 · 2024 $815 · 2025 $488
Food & beverage: $488
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $144 |
| ABBVIE INC. | 6 | $98 |
| Astellas Pharma US Inc | 3 | $64 |
| PFIZER INC. | 2 | $39 |
| Sumitomo Pharma America, Inc. | 2 | $29 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
| Phathom Pharmaceuticals, Inc. | 1 | $19 |
| Lilly USA, LLC | 1 | $16 |
| Exact Sciences Corporation | 1 | $16 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $16 |
Products named: Ozempic, VRAYLAR, Veozah, Wegovy, GEMTESA, ELIQUIS, CAPLYTA, VOQUEZNA.
Industry payments across GA — which companies pay providers there.
